TreeHouse Foods, Inc. (NYSE:THS) shares are trading slightly lower on Friday.

The company voluntarily recalled specific frozen waffle products due to the potential risk of contamination with Listeria monocytogenes.

This organism can lead to serious and sometimes fatal infections, particularly in young children, elderly individuals, and those with weakened immune systems.

The affected products were distributed across the U.S. and Canada and are packaged in various formats.

Healthy people, however, may experience only mild symptoms, such as high fever, severe headache, stiffness, nausea, abdominal pain, and diarrhea. Listeria monocytogenes infections can also result in miscarriages and stillbirths in pregnant women.

Also Read: Goldman Sachs Highlights 20 Top Short-Squeeze Opportunities For Q3 Earnings Season

The company stated that no confirmed illness reports have been associated with the recalled products to date. This issue was identified during routine testing at the manufacturing facility.

Consumers are advised to either dispose the listed products or return them to the place of purchase for a refund. This recall is being conducted in cooperation with the U.S. Food and Drug Administration (FDA) and the Canadian Food Inspection Agency (CFIA).

According to Benzinga Pro, THS stock has gained 0.6% in the past year. Investors can gain exposure to the stock via Invesco S&P SmallCap Consumer Staples ETF (NASDAQ:PSCC) and LeaderShares Activist Leaders ETF (NYSE:ACTV).

Price Action: THS shares are trading lower by 0.72% to $41.89 at last check Friday.

Image via Shutterstock

Read Now:

• ‘Most Widely Hated' Bull Market Reaches 2-Year Milestone: Top 20 S&P 500 Stocks Driving The Rally

UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets.

Get the latest stock analysis from Benzinga?

• TREEHOUSE FOODS (THS): Free Stock Analysis Report

This article What's Going On With TreeHouse Foods Stock Today? originally appeared on Benzinga.com

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.